Recipharm Appoints New GM
This article was originally published in Scrip
Executive Summary
Recipharm, a contract development and manufacturing organization, has appointed Yves Buelens general manager for its wholly owned new subsidiary, Kaysersberg Pharmaceuticals SAS. Buelens has been the plant manager for the Kaysersberg facility since 2014. Kaysersberg employs around 260 people. The company, including its main asset a manufacturing facility in Alsace, France, was acquired by Recipharm Dec. 31, 2015. The facility was previously acquired by Alcon in 1984.